Adagene Inc. - stock earnings
ADAG Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -4.1 million USD | 17.3 million USD |
| 2023Q1 | -32.2 million USD | 5.3 million USD |
| 2022Q3 | -16.2 million USD | 2.7 million USD |
| 2022Q2 | -23.8 million USD | 2.0 million USD |
| 2022Q1 | -42.7 million USD | 9.3 million USD |
| 2021Q4 | -18.0 million USD | 4.4 million USD |
| 2021Q3 | -18.0 million USD | 4.4 million USD |
| 2021Q2 | -18.6 million USD | 679418 USD |
| 2021Q1 | 13.2 million USD | 170500 USD |
| 2020Q4 | 13.2 million USD | 170500 USD |
| 2020Q3 | -11.5 million USD | ? USD |
| 2020Q2 | -9.1 million USD | 154750 USD |
| 2020Q1 | -9.1 million USD | 154750 USD |
| 2019Q4 | -5.2 million USD | 480000 USD |
ADAG Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -80.0 million USD | 9.3 million USD |
| 2021 | -73.2 million USD | 10.2 million USD |
| 2020 | -16.4 million USD | 480000 USD |
| 2019 | -17.3 million USD | 480000 USD |
| 2018 | -14.7 million USD | 1.5 million USD |
ADAG
Price: $2.41
52 week price:
Earnings Per Share: -0.86 USD
P/E Ratio: -4.13
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 47600
Market Capitalization: 125.7 million